US Becomes 1st Country To Approve Respiratory Syncytial Virus Vaccine

RSV is a common virus that normally causes mild, cold-like symptoms. (Representational) Washington: The United States on Wednesday approved the world’s first vaccine for the Respiratory Syncytial Virus (RSV), the culmination of a decades-long hunt to protect vulnerable people from the common illness. Drugmaker GSK’s Arexvy was green-lighted for adults aged 60 and older, with […]